Experimental Hematology
Volume 37, Issue 1 , Pages 92-100 , January 2009

Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT

  • Motoyuki Suzuki

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan
    • Division of Functional Genomics & Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama, Japan
    • Corresponding Author InformationOffprint requests to: Motoyuki Suzuki, M.S. Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories Inc., 675–1 Fujisaki, Okayama 702–8006, Japan
    • ,
  • Akira Sugimoto

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan
    • ,
  • Akira Harashima

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan
    • ,
  • Takeshi Otani

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan
    • ,
  • Mayuko Yamamoto

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan
    • ,
  • Shuji Nakamura

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan
    • ,
  • Fumiyuki Yamasaki

      Affiliations

    • Kurashiki Medical Center, Bakuro-cho, Kurashiki, Okayama, Japan
    • ,
  • Masahiko Nishiyama

      Affiliations

    • Translational Research Center, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
    • ,
  • Yasushi Okazaki

      Affiliations

    • Division of Functional Genomics & Systems Medicine, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama, Japan
    • ,
  • Masayoshi Kibata

      Affiliations

    • Cell Biology Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Okayama, Japan

Received 20 May 2008 ,Revised 28 July 2008 ,Accepted 22 September 2008.

References 

  1. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562
  2. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005;6:345–352
  3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–1164
  4. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003;4:337–342
  5. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol. 2003;15:430–435
  6. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–336
  7. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–1061
  8. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol. 2005;6:338–344
  9. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005;6:331–337
  10. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF alpha therapy. J Exp Med. 2004;200:277–285
  11. Zorn E, Kim HT, Lee SJ, et al. Reduced frequency of FOXP3+CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood. 2005;106:2903–2911
  12. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev. 2001;182:68–79
  13. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev. 2001;182:207–214
  14. Grossman WJ, Verbsky JW, Barchaet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21:589–601
  15. Michel G, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med. 2002;195:695–704
  16. Horwitz DA, Zheng SG, Gray JD. The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets. J Leuk. Biol. 2003;74:471–478
  17. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanism of suppression. Trends Mol Med. 2007;13:108–116
  18. Vandenborre K, Vangool SW, Kasran A, Ceuppens JL, Boogaerts MA, Vandenberghe P. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Immunology. 1999;98:413–421
  19. Huang CT, Workman CJ, Flies D, et al. Role of LAG-3 in regulatory T cells. Immunity. 2004;21:503–513
  20. Ji HB, Liao G, Faubion WA, et al. The natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol. 2004;172:5823–5827
  21. Nakamura S, Suzuki M, Sugimoto A, et al. IL-2-independent generation of FOXP3+CD4+CD8+CD25+ cytotoxic regulatory T cell lines from human umbilical cord blood. Exp Hematol. 2007;35:287–296
  22. Otani T, Inoue T, Tsuji-Takayama K, et al. Progenitor analysis of primitive erythropoiesis generated from in vitro culture of embryonic stem cells. Exp Hematol. 2005;33:632–640
  23. Lee MS, Hanspers K, Barker CS, Korn AP, McCune JM. Gene expression profiles during human CD4+ T cell differentiation. Int Immunol. 2004;16:1109–1124
  24. Freeman GJ, Long AJ, Iwai Y, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192:1027–1034
  25. Le Rond S, Azéma C, Krawice-Radanne I, et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol. 2006;176:3266–3276
  26. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 2005;19:681–693
  27. Favier B, LeMaoult J, Carosella ED. Functions of HLA-G in the immune system. Tissue Antigens. 2007;69:150–152
  28. Feger U, Tolosa E, Huang YH, et al. HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood. 2007;110:568–577
  29. Kubach J, Lutter P, Bopp T, et al. Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood. 2007;110:1550–1558
  30. Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007;450:566–569
  31. Ramhorse RE, Garcia VE, Corigliano A, Rabinovich GA, Fainboim L. Identification of RANTES as a novel immunomodulator of the maternal allogeneic response. Clin Immunol. 2004;110:71–80

PII: S0301-472X(08)00439-6

doi: 10.1016/j.exphem.2008.09.010

Experimental Hematology
Volume 37, Issue 1 , Pages 92-100 , January 2009

Article Tools

* Image Usage & Resolution